Orum Therapeutics Presents Preclinical Data at ASH 2025 Demonstrating Potent and Selective Antitumor Activity of ORM-1153, a CD123-Targeting Degrader Antibody Conjugate for Acute Myeloid Leukemia Orum ...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--#ADC--Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

A simple console-based Java application using Hibernate ORM and MySQL for managing employee data. Supports basic CRUD operations like Add, View, Update, and Delete.

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Orum Therapeutics Inc. on April 26 pulled the plug on a U.S.-based phase I study of ORM-5029, its lead oncology degrader antibody conjugate (DAC) asset, a decision that came months after the company ...

She shares how Orm in real life compares to Orm in the movie, takes us behind the scenes with fun stories, and lets her charming personality shine throughout the interview.

Get ready to fall in love with ORM! 💕 In this special episode of Time to Talk, Kornnaphat Sethratanapong opens up about her role as Orm in Will You Marry Monk? (แต่งมั้ง) and what makes this ...